Ambu A/s Class B · OMXCOP:AMBU_B

Ambu A/s Class B — Q1 2009/10 Earnings Presentation

19 slides from Ambu A/s Class B's earnings presentation

1. Slide 1: Interim Report Q1 2009/10

   INTERIM REPORT Q1 2009/10 By CEO Lars Marcher and CFO Anders Arvai

2. Slide 2: Agenda

   AGENDA ƒ Developments in Q1 2009/10 ƒ Strategy GPS Four – follow-up ƒ Outlook for 2009/10

3. Slide 3: Highlights (1) Business Development

   HIGHLIGHTS (1) BUSINESS DEVELOPMENT ƒ Good Q1. Both revenue and EBIT up relative to last year ƒ Organic growth of 7% – higher than market growth ƒ Gross profit margin increased to 53.1 from 50.2 in Q1 2008/09 ƒ EBIT improved by 22% ƒ Transfer of production going according to plan ƒ Implementation of

4. Slide 4: Highlights (2) Financial Development Q1 2009/10

   HIGHLIGHTS (2) FINANCIAL DEVELOPMENT Q1 2009/10 ƒ Revenue increased to DKK 213m – up 7% in local currencies (2% in DKK) ƒ EBIT amounted to DKK 19m against DKK 15m in Q1 2008/09 ƒ EBIT margin of 9% against 7% in Q1 2008/09 ƒ Profit before tax of DKK 17m, which is on a par with Q1 2008/09 ƒ Free cash

5. Slide 5: Revenue

   REVENUE ƒ Increase in revenue in Q1 2009/10 of 7% in local currencies ƒ Changes in exchange rates had a negative effect corresponding to DKK 9m ƒ Revenue in Q1 calculated at last year’s exchange rates of DKK 222m ƒ Growth in the USA of 11% and growth in Europe of 9% measured in local currencies Reve

6. Slide 6: Developments within Business Areas

   DEVELOPMENTS WITHIN BUSINESS AREAS Airway Management ƒ Increase in revenue of 13% in local currencies – 8% measured in DKK ƒ Market share is still being won within the laryngeal masks product area ƒ Launch of Ambu aScope (new single-use videoscope) has been satisfactory, and sales are developing as

7. Slide 7: Developments within Geographical Areas

   DEVELOPMENTS WITHIN GEOGRAPHICAL AREAS Europe ƒ Growth in revenue of 9%, or 8% in local currencies ƒ Satisfactory growth in core markets ƒ Growth in revenue in sales territories UK of 12% and Central (Germany, Austria and Switzerland) of 10% ƒ Growth in revenue of approx. 7% in sales territories Wes

8. Slide 8: Operating Profit and Net Financials

   OPERATING PROFIT AND NET FINANCIALS ƒ EBIT after special items of DKK 19m against DKK 15m in Q1 2008/09 ƒ Special items of DKK 0.5m in the form of legal fees, lower than in Q1 2008/09 ƒ Selling costs up due to full effect of expansion of sales force in the USA and the UK in 2008/09 ƒ EBIT margin aft

9. Slide 9: Improved Cash Flow

   IMPROVED CASH FLOW DKKm Q1 2008/09 Q1 2009/10 Cash flow from operating activities (1.4) (1.1) Cash flow from investing activities, including acquisitions (40.0) (13.5) Free cash flow after acquisitions (45.4) (14.5) ƒ Cash flow from operating activities negatively impacted by funds tied in working c

10. Slide 10: GPS Four: Ambu's New Business Strategy

    GPS FOUR AMBU’S NEW BUSINESS STRATEGY

11. Slide 11: GPS1 Products and Product Development

    GPS1 PRODUCTS AND PRODUCT DEVELOPMENT ƒ Innovation strategy has been prepared and will ensure the ongoing launch of new and exciting products ƒ aScope launched in Europe and Asia. To be marketed in the USA later in the year ƒ European version of single-use ventilation bag launched ƒ Wireless manikin

12. Slide 12: GPS2 Markets and Sales

    GPS2 MARKETS AND SALES ƒ Merger of sales areas to form new sales territories completed ƒ Increase of sales force in 2008/09 in the USA and the UK takes full effect in 2009/10 ƒ Newly established sales company in Australia developing as expected ƒ Establishment of branch in Poland due to growing East

13. Slide 13: GPS3 Efficiency

    GPS3 EFFICIENCY ƒ Logistics forecasting and planning system implemented ƒ Group ERP system implemented in the USA ƒ System designed to increase the efficiency of global development function – PLM system – going according to plan ƒ Phase one of the transfer of electrode production from Denmark to Mal

14. Slide 14: GPS4 Acquisitions

    GPS4 ACQUISITIONS ƒ Ongoing dialogue with potential candidates for acquisition ƒ Focus on acquisition of product areas or entire companies ƒ Acquisitions primarily within areas which will strengthen company’s position within single- use products for the hospital sector 14

15. Slide 15: Outlook for 2009/10

    .AAmbut OUTLOOK FOR 2009/10 The Future

16. Slide 16: Market Challenges

    MARKET CHALLENGES ƒ Global crisis still having a limited impact ƒ Despite good growth in the US market, the health care sector remains under pressure ƒ In some markets in southern Europe, pressure on the health care sector is mounting ƒ Despite intensifying competition, Ambu is winning market share

17. Slide 17: Outlook for 2009/10 (2)

    OUTLOOK FOR 2009/10 (2) 2009/10 Assumptions Revenue, DKKm 900-925 Launch of new products Growth, % 3-5 Growth exceeding market growth Growth in local currencies, % 5-6 Intensified sales efforts USD exchange rate: 500 GBP exchange rate: 840 EBIT margin before special items 1) 12-12.5 Increase in reve

18. Slide 18: Questions

    Ideas that work for life QUESTIONS

19. Slide 19: Read more at www.ambu.com

    READ MORE AT WWW.AMBU.COM For further information, please contact: Lars Marcher, CEO, lm@ambu.com or +45 5136 2490 Anders Arvai, CFO, aa@ambu.com or +45 7225 2000

Ambu — Q1 2009/10 Earnings Presentation on 6ix